Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JNJ-39758979 in Active Rheumatoid Arthritis
NCT01480388Phase 2Withdrawn
- Sponsor
- Janssen Pharmaceutical
- Start
- Dec 2011
- Primary completion
- Mar 2014
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of JNJ-39758979 in rheumatoid arthritis (RA), sponsored by Janssen Pharmaceutical. Planned start Dec 2011; status: withdrawn.
02
Drugs
JNJ-39758979
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01480388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01480388.